These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2969106)

  • 1. [Immunological characteristics of patients with diffuse toxic goiter].
    Sekhniashvili ZSh
    Probl Endokrinol (Mosk); 1988; 34(2):3-5. PubMed ID: 2969106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment].
    Epishin AV
    Klin Med (Mosk); 1984 Aug; 62(8):90-3. PubMed ID: 6333549
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of immunological reactivity of patients with diffuse toxic goiter in relation to the duration of the disease].
    Aliev TA; Nasibov AI
    Probl Endokrinol (Mosk); 1986; 32(3):7-10. PubMed ID: 3755533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of interleukin 2 production in patients with diffuse toxic goiter under the influence of treatment].
    Shatsova EN; Malaitsev VV; Bogdanova IM
    Probl Endokrinol (Mosk); 1988; 34(6):24-6. PubMed ID: 2976937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the immune status indices of patients with diffuse toxic goiter in different stages of the disease].
    Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1985; 31(6):6-10. PubMed ID: 3841395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-immunological parallels in diffuse toxic goiter].
    Kuleshov EV; Diachuk IA; Deĭkalo IN; Gnatiuk MS
    Sov Med; 1986; (8):29-33. PubMed ID: 3490701
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of various indicators of cellular immunity in patients with diffuse toxic goiter after drug therapy].
    Nugmanova LB; Garib FIu; Ismailov SI; Aripov DA
    Probl Endokrinol (Mosk); 1986; 32(3):17-21. PubMed ID: 2874552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease.
    Pacini F; DeGroot LJ
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):219-32. PubMed ID: 6222851
    [No Abstract]   [Full Text] [Related]  

  • 11. [T-lymphocyte subpopulations in the blood of patients with chronic B-cell lympholeukemia studied using monoclonal antibodies].
    Karminskaia NM; Merson AG; Gipsh NM; Udris OIu; Iavorkovskiĭ LI
    Eksp Onkol; 1986; 8(3):50-3. PubMed ID: 2941268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indices of the T- and B-immunity systems in goiter patients].
    Epishin AV
    Vrach Delo; 1983 May; (5):91-3. PubMed ID: 6603713
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients].
    Epishin AV
    Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):162-4. PubMed ID: 2144488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic abnormalities in amyotrophic lateral sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):195-8. PubMed ID: 3157286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of the immune status and the role of the T-lymphocyte subpopulation in the acute period of craniocerebral injuries].
    Gorbunov VI
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (3):28-31. PubMed ID: 2970750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indicators of the T- and B-systems of immunity in patients with diffuse toxic goiter].
    Vnotchenko SL; Aleksandrova GF; Mktrumova NA
    Probl Endokrinol (Mosk); 1983; 29(1):23-7. PubMed ID: 6601270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preasthma and bronchial asthma: problems of clinical immunology].
    Bakulin MP; Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu
    Ter Arkh; 1987; 59(12):33-9. PubMed ID: 2965832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
    Moore K; Nesbitt AM
    Immunology; 1987 Jun; 61(2):159-65. PubMed ID: 2954898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.